This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Nov;154(5):e23; author reply e25.

doi: 10.1016/j.ahj.2007.07.044. Epub 2007 Sep 14.

Beta blockers in systolic heart failure: do physicians need more courage?

Mehmet Birhan Yilmaz, Meltem Refiker

PMID: 17967570
DOI: 10.1016/j.ahj.2007.07.044

Comment

Beta blockers in systolic heart failure: do physicians need more courage?

Mehmet Birhan Yilmaz et al. Am Heart J. 2007 Nov.

. 2007 Nov;154(5):e23; author reply e25.

doi: 10.1016/j.ahj.2007.07.044. Epub 2007 Sep 14.

Authors

Mehmet Birhan Yilmaz, Meltem Refiker

PMID: 17967570
DOI: 10.1016/j.ahj.2007.07.044

No abstract available

PubMed Disclaimer

Comment on

Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
Patel P, White DL, Deswal A. Patel P, et al. Am Heart J. 2007 Apr;153(4):515-22. doi: 10.1016/j.ahj.2007.01.037. Am Heart J. 2007. PMID: 17383287

Similar articles

Surrogate end points in heart failure trials.
Gheorghiade M, Adams KF Jr, Gattis WA, Teerlink JR, Orlandi C, O'Connor CM. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S67-70. doi: 10.1067/mhj.2003.159. Am Heart J. 2003. PMID: 12594457 No abstract available.
Beta-blockers in elderly patients with heart failure ready for prime time?
Lainscak M, Duengen HD, Anker SD. Lainscak M, et al. J Am Coll Cardiol. 2009 Dec 1;54(23):2202. doi: 10.1016/j.jacc.2009.02.093. J Am Coll Cardiol. 2009. PMID: 19942096 No abstract available.
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF Jr, Hill JA, Aranda JM Jr, Johnson JA. Lobmeyer MT, et al. Pharmacogenet Genomics. 2007 Apr;17(4):277-82. doi: 10.1097/FPC.0b013e3280105245. Pharmacogenet Genomics. 2007. PMID: 17496726
[Beta-blockers in cardiac insufficiency. Time to reconsider?].
Follath F. Follath F. Schweiz Med Wochenschr. 1996 May 4;126(18):747-9. Schweiz Med Wochenschr. 1996. PMID: 8693298 Review. German. No abstract available.
Question: does beta-blocker therapy improve outcomes in patients with congestive heart failure with normal left ventricular function (diastolic dysfunction)?
Cafaro B, Barr S, Brand JL. Cafaro B, et al. J Okla State Med Assoc. 2010 Feb;103(2):51-2. J Okla State Med Assoc. 2010. PMID: 20306621 Review. No abstract available.

See all similar articles

Cited by

Managing beta-blockers in acute heart failure: when to start and when to stop?
Yilmaz MB, Laribi S, Mebazaa A. Yilmaz MB, et al. Curr Heart Fail Rep. 2010 Sep;7(3):110-5. doi: 10.1007/s11897-010-0014-8. Curr Heart Fail Rep. 2010. PMID: 20544326 Review.
Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
Ege MR, Guray U, Guray Y, Yilmaz MB, Yucel O, Zorlu A, Tandogan I. Ege MR, et al. Herz. 2012 Nov;37(7):796-800. doi: 10.1007/s00059-012-3641-x. Epub 2012 Jun 16. Herz. 2012. PMID: 22699995 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information